James Howard Hedrick, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 North Main, Kingston, OK 73439 Phone: 580-564-2337 |
Dr. Sheriden Cheyenne Franks, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7 North Main Street, Kingston, OK 73439 Phone: 580-564-2337 Fax: 580-564-2331 |
News Archive
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Road salt applied during the winter lingers in the environment, where it can pollute drinking water supplies. In a recent study in the Journal of Environmental Quality, researchers identify landscape and geological characteristics linked to elevated well water salinity in a suburban township in Southeastern New York.
Deaths from cervical cancer could jump fourfold to a million a year by 2050, mainly in developing countries. This could be prevented by soon-to-be-approved vaccines against the virus that causes most cases of cervical cancer- but there are signs that opposition to the vaccines might lead to many preventable deaths. The trouble is that the human papilloma virus (HPV) is sexually transmitted.
Americans have had little understanding of the Affordable Care Act since it became law in 2010. With major provisions taking effect in January, half the country still does not know what the law does or what it means for them. While some of the confusion is no doubt due to the law's complexity and the highly charged political environment, a largely ignored but central factor is that people know little about the deeply flawed health insurance system that got us to this place (John Seffrin and Jim Guest, 9/17).
The U.S. Food and Drug Administration today announced the availability of $2 million in research grants to fund natural history studies in rare diseases. The aim is to collect data on how specific rare diseases progress in individuals over time so that knowledge can inform and support product development and approval. This will be the first time the FDA will provide funding through its Orphan Products Grants to conduct these types of studies for rare diseases.
› Verified 3 days ago